Sort

Search

01/06/2024 Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation
Luquero, A, Pimentel, N, Vilahur, G, Badimon, L, Borrell-Pages, M. Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(12)DOI:10.3390/ijms25126763. PMID:38928468. IF:4.900(Q1/3D).
01/06/2024 LRP5 and canonical WNT pathway in brain development
Pimentel, N, Luquero, A, Arderiu, G, Vilahur, G, Badimon, L, Borrel-Pages, M. LRP5 and canonical WNT pathway in brain development. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Clustered microRNAs involved in vascular remodelling in diabetic adipose-derived stem cells: A role for basic fibroblast growth factor
Civit-Urgell, A, Badimon, L, Arderiu, G. Clustered microRNAs involved in vascular remodelling in diabetic adipose-derived stem cells: A role for basic fibroblast growth factor. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Heart-brain crosstalk during myocardial infarction: Changes in the brain following experimental myocardial infarction
Otero, S, Gallinat, G, Badimon, L. Heart-brain crosstalk during myocardial infarction: Changes in the brain following experimental myocardial infarction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Impact of ApoM-S1P and anti-miR-126-5p on the different cardiac cell populations: Identification of potential HDL-nanoconstructs to protect the infarcted heart
Ramos, L, Schoch, L, Alcover, S, Arderiu, G, Borrell, M, Magaldi, M, Barriuso, I, Suades, R, Padró, T, Badimon, L, Zaragoza, C, ZVilahur, G. Impact of ApoM-S1P and anti-miR-126-5p on the different cardiac cell populations: Identification of potential HDL-nanoconstructs to protect the infarcted heart. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Lp(a) and coronary artery calcium associates to a distinctive miRNA signature in patients with familial hypercholesterolemia and subclinical atherosclerosis
Escate, R, Padró, T, Mata, P, Muñoz-Torrero, JS, Diaz-Diaz, J, Badimon, L. Lp(a) and coronary artery calcium associates to a distinctive miRNA signature in patients with familial hypercholesterolemia and subclinical atherosclerosis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Protective effects of intravenous atorvastatin on the axis ischemic heart to the brain: Preclinical study in pigs
Magaldi, M, Borrell, M, Alcover, S, Ramos, L, Arderiu, G, Casani, L, Padro, T, Badimon, L, Vilahur, G. Protective effects of intravenous atorvastatin on the axis ischemic heart to the brain: Preclinical study in pigs. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation
Ligero, C, Riera, P, El-Amrani, A, Bazan, V, Guerra, JM, Herraez, S, Viñolas, X, Alegret, JM. Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation. Pharmaceuticals. 2024; 17(6)DOI:10.3390/ph17060693. PMID:38931360. IF:4.800(Q1/2D).
01/06/2024 Apolipoproteins and Lipoproteins in Health and Disease 2.0
Rotllan, N, Escolà-Gil, JC. Apolipoproteins and Lipoproteins in Health and Disease 2.0. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(11)DOI:10.3390/ijms25116183. PMID:38892369. IF:4.900(Q1/3D).
01/06/2024 Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes
Illana, FJ, García-Osuna, A, Sospedra, M, Ferrer, R, Martínez-Brú, C, Guiñón, L. Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes. Biochemia Medica. 2024; 34(2)DOI:10.11613/BM.2024.020704. PMID:38665870. IF:1.800(Q3/6D).
01/06/2024 Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia
Lhoëst, MTL, Samouillan, V, García, E, Amaro, AB, Dandurand, J, Dato, VA, Guerra, JM, Escolà-Gil, JC, Chiabrando, G, Enrich, C. Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review
Masson, W, Barbagelata, L, Godinez-Leiva, E, Genua, I, Nogueira, JP. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review. Indian Journal Of Gastroenterology. 2024; 43(3)DOI:10.1007/s12664-023-01457-2. PMID:38036914. IF:(Q/D).
01/06/2024 The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area
Rojo-López, MI, Barranco-Altirriba, M, Rossell, J, Antentas, M, Castelblanco, E, Yanes, O, Weber, RJM, Lloyd, GR, Winder, C, Dunn, WB, Julve, J, Granado-Casas, M, Mauricio, D. The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area. Nutrients. 2024; 16(12)DOI:10.3390/nu16121805. PMID:38931159. IF:5.000(Q1/2D).
01/06/2024 The Polypill: A New Alternative in the Prevention and Treatment of Cardiovascular Disease
Espinosa, EVP, Matute, EM, Guzman, DMS, Khasawneh, FT. The Polypill: A New Alternative in the Prevention and Treatment of Cardiovascular Disease. Journal of Clinical Medicine. 2024; 13(11)DOI:10.3390/jcm13113179. PMID:38892892. IF:2.900(Q1/2D).
01/06/2024 Sex-specific disparities in dietary patterns and their association with metabolic-associated fatty liver disease
Peraile, MA, Rojo-López, MI, Vlacho, B, Rossell, J, Vendrell, P, Genua, I, Fernández-Camins, B, Granado-Casas, M, Mauricio, D, Julve, J. Sex-specific disparities in dietary patterns and their association with metabolic-associated fatty liver disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey
Cherenko, M, Appelman-Dijkstra, NM, Zurita, ALP, Biermasz, NR, Dekkers, OM, Klok, FA, Reisch, N, Aulinas, A, Biagetti, B, Cannavo, S, Canu, L, Detomas, M, Devuyst, F, Falhammar, H, Feelders, RA, Ferrau, F, Gatto, F, Grasselli, C, van Houten, P, Hoybye, C, Isidori, AM, Kyrilli, A, Loli, P, Maiter, D, Nowak, E, Pivonello, R, Ragnarsson, O, Steenaard, R, Unger, N, van de Ven, A, Webb, SM, Yeste, D, Ahmed, SF, Pereira, AM. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey. Endocrine Connections. 2024; 13(6)DOI:10.1530/EC-24-0046. PMID:38614126. IF:2.800(Q3/6D).
01/06/2024 Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Guerra, I, Barros, F, Chaparro, M, Benítez, JM, Martín-Arranz, MD, de Francisco, R, Piqueras, M, de Castro, L, Carbajo, AY, Bermejo, F, Mínguez, M, Gutiérrez, A, Mesonero, F, Cañete, F, González-Muñoza, C, Calvo, M, Sicilia, B, Alfambra, E, Rivero, M, Lucendo, AJ, Tardillo, CA, Almela, P, Bujanda, L, van Domselaar, M, Ramos, L, Sánchez, MF, Hinojosa, E, Verdejo, C, Gimenez, A, Rodriguez-Lago, I, Manceñido, N, Calle, JLP, Moreno, MD, Delgado-Guillena, PG, Antolin, B, de la Piscina, PR, Casanova, MJ, Escribano, PS, Arranz, EM, Perez-Martínez, I, Mena, R, Morales, NG, Granja, A, Watts, MMB, Francés, R, Fernandez, C, Calafat, M, Roig-Ramos, C, Vera, MI, Carracedo, A, Domènech, E, Gisbert, JP. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry. DIGESTIVE DISEASES. 2024; 42(3)DOI:10.1159/000537782. PMID:38452742. IF:2.100(Q3/7D).
01/06/2024 The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice
Gutiérrez-Rios, L, Calafat, M, Pascual, I, Roig, C, Teniente-Serra, A, Vergés, L, González-Muñoza, C, Vayreda, E, Vázquez, D, Gordillo, J, Mañosa, M, Ramírez, C, Garcia-Planella, E, Planella, M, Domènech, E. The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice. Nutrients. 2024; 16(11)DOI:10.3390/nu16111633. PMID:38892566. IF:5.000(Q1/2D).
01/06/2024 Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant
Torras, C, Bañares, J, Martí, A, Acin, V, Pagès, L, Gutiérrez, L, Casabella, A, Ferrusquía, JA, Sánchez, J, Pérez, M, Fuertes, D, Garcia, M, Soriano, G, Masnou, H, Amador, A, Cuyas, B, Pericàs, JM, Gasch, O, Solé, C. Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis
Fernández, J, Núñez, L, Costa, M, Torres, M, Horrillo, R, Afonso, N, Mestre, A, Del Arbol, LR, Villanueva, C, Paez, A, Arroyo, V. Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG <10 mmHg and NITs within the grey zone
Alberch, PO, Soler, A, Téllez, L, Carrión, JA, Alvarado-Tapias, E, Ferrusquía, JA, Lens, S, Guerrero, A, Falgà, MA, Vizcarra, P, Orts, L, Perez, V, Shalaby, S, Baiges, A, Turon, F, García-Pagán, JC, García-Criado, MA, Hernández-Gea, V. Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG <10 mmHg and NITs within the grey zone. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Ballester, MP, Laue, T, Meoli, L, Uson, E, Mutschler, F, Grabitz, C, McLin, V, D'Antiga, L, Pujadas, M, Carvalho-Gomes, A, Sahuco, I, Bono, A, D'Amico, F, Viganò, R, Sempere, ED, Tormo, B, Inglese, E, Martinez, D, Riva, A, Sharma, R, Tsou, HLP, Harris, N, Broekhoven, A, Kikkert, M, Morales, S, Myeni, S, Barciela, MR, Palom, A, Zeni, N, Brocca, A, Cussigh, A, Cmet, S, Escudero-García, D, Stocco, M, Natola, L, Ieluzzi, D, Paon, V, Sangiovanni, A, Farina, E, Di Benedetto, C, Sanchez-Torrijos, YM, Valera, AL, Roman, E, Sanchez, E, Sánchez-Aldehuelo, R, López-Cardona, J, Canas-Perez, I, Jackson, C, Jeyanesan, D, Morocho, AE, Di Cola, S, Lapenna, L, Zaccherini, G, Bongiovanni, D, Zanaga, P, Sayaf, K, Hossain, S, Crespo, J, Robles-Díaz, M, Madejón, A, Degroote, H, Fernández, J, Korenjak, M, Verhelst, X, Garcia-Samaniego, FJ, Andrade, RJ, Iruzubieta, P, Wright, G, Caraceni, P, Merli, M, Patel, VC, Gander, A, Albillos, A, Soriano, G, Donato, MF, Sacerdoti, D, Toniutto, P, Buti, M, Duvoux, C, Grossi, PA, Berg, T, Polak, W, Puoti, M, Bosch, A, Belli, LS, Burra, P, Russo, FP, Coenraad, M, Panero, JLC, Perricone, G, Chokshi, S, Berenguer, M, Clària, J, Moreau, R, Arroyo, V, Angeli, P, Sanchez, C, Ampuero, J, Piano, S, Nicastro, E. Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Chronic pancreatitis for the clinician: complications and special forms of the disease. Interdisciplinary position paper of the Catalan Society of Digestology (SCD) and the Catalan Pancreatic Society (SCPanc)
Molero, X, Ayuso, JR, Balsells, J, Boadas, J, Busquets, J, Casteras, A, Concepcion, M, Cuatrecasas, M, Esparrach, GF, Fort, E, Borobia, FG, Gines, A, Ilzarbe, L, Loras, C, Masachs, M, Merino, X, Olsina, JJ, Puig-Divi, V, Salord, S, Serrano, T, Vaquero, EC. Chronic pancreatitis for the clinician: complications and special forms of the disease. Interdisciplinary position paper of the Catalan Society of Digestology (SCD) and the Catalan Pancreatic Society (SCPanc). Minerva Gastroenterology. 2024; 70(2)DOI:10.23736/S2724-5985.22.03127-8. PMID:35262306. IF:1.500(Q4/8D).
01/06/2024 Incidence of herpes zoster in patients with inflammatory bowel disease
Calm, A, Calafat, M, González-Muñoza, C, Cañete, F, Roig, C, Mañosa, M, García-Planella, E, Domènech, E. Incidence of herpes zoster in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(6)DOI:10.1016/j.gastrohep.2024.01.011. PMID:38316174. IF:1.900(Q3/7D).
01/06/2024 Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort
Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).
01/06/2024 The impact of smoking on bronchiectasis and its comorbidities
de la Rosa-Carrillo, D, de Granda-Orive, JI, Cáceres, LD, Pereyra, FG, Moreno, BR, Martínez-Garcia, MA, Suárez-Cuartin, G. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine. 2024; 18(5)DOI:10.1080/17476348.2024.2369716. PMID:38888096. IF:2.700(Q2/5D).
01/06/2024 BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID)
Lugogo, NL, Heffler, E, Plaza,, Hilberg, O, Xia, C, Nash, S, Pandit-Abid, N, Jacob-Nara, JA, Sacks, H, Rowe, PJ, Deniz, Y, Hardin, M, Reed, C, Soler, X. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID). VALUE IN HEALTH. 2024; 27(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/06/2024 Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients
Suades, R, Padró, T, Domingo, P, Greco, MF, Benincasa, G, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Global cooperation and early access-clinical outcomes matter
Tibau, A, Kesselheim, AS. Global cooperation and early access-clinical outcomes matter. LANCET ONCOLOGY. 2024; 25(6)DOI:10.1016/S1470-2045(24)00210-9. PMID:38754452. IF:35.900(Q1/1D).
01/06/2024 Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM). JOURNAL OF NEURO-ONCOLOGY. 2024; 168(2)DOI:10.1007/s11060-024-04668-5. PMID:38630385. IF:3.100(Q2/4D).
01/06/2024 Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies
Tibau, A, Hwang, TJ, Avorn, J, Kesselheim, AS. Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024 Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study
Serda, PC, Cullell, BM, Castet, F, Gatell, AP, Fernandez, PR, Fernandez, J, Nadal, TS, Mateo, FJP, Sorolla, MA, Cajal, TRY. Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/annonc.2024.05.508. PMID:. IF:65.400(Q1/1D).
01/06/2024 Preliminary results correlating post-operative ctDNA status with disease-free survival in patients with stage II (high risk)/III colorectal cancer in the BNT000-001 epidemiology study
Reinacher-Schick, AC, Lopez, MR, Alonso-Orduña, V, Lopez-Bravo, DP, Vergauwe, P, Tannapfel, A, Silveira, AB, Schlombs, K, Young, P, He, Y, Henn, H, Manning, L, Preussner, L, Mueller, F, Sahin, U, Türeci, O. Preliminary results correlating post-operative ctDNA status with disease-free survival in patients with stage II (high risk)/III colorectal cancer in the BNT000-001 epidemiology study. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024 The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families (vol 73, 103611, 2024)
Schreurs, MAC, Cajal, TRY, Adank, MA, Collée, JM, Hollestelle, A, van Rooij, J, Schmidt, MK, Hooning, MJ. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families (vol 73, 103611, 2024). BREAST. 2024; 75DOI:10.1016/j.breast.2024.103723. PMID:. IF:7.900(Q1/1D).
01/06/2024 Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC)
Aggarwal, C, Martinez-Marti, A, Majem, M, Barlesi, F, Carcereny, E, Chu, QS, Monnet, I, Sanchez, A, Dakhil, SR, Camidge, DR, Pillet, M, Brown, M, Dowson, A, Cooper, ZA, Kumar, R, Herbst, RS. Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024 Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801
Berciano-Guerrero, MA, Perez-Ruiz, E, Couselo, EM, Manzano, JL, Cerezuela-Fuentes, P, de Miguel, PA, Soria, A, Castaño, AG, Crespo, G, Puértolas, T, De La Rosa, CA, Sanz, LG, Castro, RL, Espinosa, E, Lecumberri, MJ, Majem, M, Martinez, JM, Bellido, L, Fernández-Morales, LA, Martin-Algarra, S. Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024 Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study
Martelli, V, Barrull, JV, Rodriguez, CF, Alfonso, PG, Paez, D, Gibert, J, Alonso, V, España, MAG, Vivas, CS, Ogalla, GD, Fernandez, MEE, Garcia-Carbonero, R, Monteagudo, RF, Mozo, JLM, Losa, F, Paricio, BB, Tabernero, J, Soler, RS, Aguilar, EA, Viladot, CM. Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.121. PMID:. IF:65.400(Q1/1D).
01/06/2024 Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study
Taieb, J, Fakih, M, Salvatore, L, Esaki, T, Modest, DP, Paez, D, Karamouzis, MV, Ruiz, E, Kim, TW, Kuboki, Y, Meriggi, FA, Cunningham, D, Yeh, KH, Cremolini, C, Wang, J, Tran, Q, Chao, J, Chen, Z, Pietrantonio, F. Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.043. PMID:. IF:65.400(Q1/1D).
01/06/2024 Molecular residual disease (MRD) analysis from the ADAURA trial of adjuvant (adj) osimertinib in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC)
John, T, Grohe, C, Goldman, JW, Kato, T, Laktionov, KK, Bonanno, L, Tiseo, M, Majem, M, Domine, M, Ahn, MJ, Perol, M, Hartmaier, R, Robichaux, J, Bhetariya, P, Markovets, A, Rukazenkov, Y, Muldoon, C, Herbst, RS, Tsuboi, M, Wu, YL. Molecular residual disease (MRD) analysis from the ADAURA trial of adjuvant (adj) osimertinib in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024 First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas
González-Lopez, JA, Sebio, A, Hindi, N, Jimenez, M, Villarejo-Campos, P, Martin-Broto, J, Díaz-Beveridge, R, Castellanos, JFO, Andújar, RL, Alvarez, RA, Asencio, JM, Serrano, C, Conde, NR, Boix, SC, Gimenez-Salinas, LK, Garcia, JAT, Campos, AP, Lopera, E, Bertran, J, Pousa, AL. First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).